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Abstract
Introduction: Despite effective treatment, tuberculosis remains among the 
top-10 causes of death causing ~1.3 million deaths in 2017. Furthermore, 
tuberculosis infection rates have increased amongst excluded populations such 
as people misusing substances.
Objectives and design: We conducted a two London sites pilot randomized 
controlled trial to test interventions, recruitment, attrition rates and assessment 
procedures of a parallel, three-arms controlled trial to assess the effectiveness of 
tuberculosis health literacy interventions among drug dependent (heroin, crack 
cocaine or heroin and crack cocaine) population in treatment.
Results: Forty-two subjects were recruited to the pilot trial (response rate = 
26%) and randomized to three interventions (1st: Information booklet; 2nd: 
Interactive seminar; 3rd: Interactive seminar + contingency management 
targeting tuberculosis-health-related action). Baseline and post-intervention 
tuberculosis knowledge scores were obtained and re-assessed at 2-months follow 
up. The overall attrition rate was 43%. The knowledge scale had good internal 
reliability (Cronbach’s α = 0.7). Statistically significant increases in knowledge 
scores (baseline to post-intervention = 5.9 points, baseline to follow-up = 4.3) 
were recorded for the whole sample (CI = 99%; p < 0.001 for both analysis), 
but no statistically significant differences between-groups were observed  
(p = 0.7). Half of participants in the contingency management group achieved 
their health-action targets.
Conclusion: Health literacy interventions to increase knowledge about 
tuberculosis among drug users are feasible and achieve promising increases in 
knowledge and health-related actions but measures to prevent a high attrition rate 
in a large-scale trial must be introduced. The absence of difference between trial-
group outcomes suggests low-intensity interventions may achieve knowledge gain 
too. Further investigation of contingency management to promote tuberculosis-
related health behaviours is needed.
Keywords
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Despite effective treatment, Tuberculosis (TB) remains among the top-10 
causes of death causing an estimated global mortality of 1.3 million deaths 
in 2017 [1] and a leading cause of death among HIV patients [2]. This 
prompted the first UN high level meeting - United to End TB: An Urgent 
Global Response to a Global Epidemic -which set up speciﬁc targets for 
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2030: a 90% reduction in the number of TB deaths and an 
80% reduction in TB incidence [3].
Between 2000 and 2017 the absolute number of deaths from 
TB among HIV-negative people worldwide has been estimated 
to have fallen by 29% (1.8 million in 2000 and 1.3 million in 
2017) [1], but the burden of disease has shifted in EU/EEA 
member states to vulnerable, hard-to-reach, low socio-economic 
populations including homeless people, prison populations 
and those who abuse drugs and alcohol [4].
Along with the “UK Tuberculosis Strategy for 2015-2020” 
[5], updated evidence-based practices for TB management and 
treatment have been published [6] and the TB infection rate 
in England declined to 9.2 new cases per 100,000 population 
in 2017, the first time since records began it falls under 10 per 
100,000 population [7]. In 2017 the proportion of TB cases 
associated with current alcohol misuse was 4.1% (188/4,591), 
current or a history of drug misuse 5.0% (229/4,603), 
homelessness 4.7% (217/4,584), and imprisonment 4.4% 
(197/4,432), having increased from 2016 [7]. London remains 
the main focal point for TB infection with more annual cases 
than the Netherlands, Belgium, Greece and Norway combined 
[8]. Many factors have been associated with an increased risk 
of TB infection: migration [9], HIV infection, incarceration, 
living in urban areas, drug and alcohol misuse and malnutrition 
[10] among others. Hence, there is a case for improving TB 
knowledge and awareness among people who misuse substances 
to promote prevention as well as encourage early diagnosis 
and treatment [11].
Health Literacy (HL) has been conceptualized as “the cognitive 
and social skills which determine the motivation and abilities of 
individuals to gain access to, understand and use information 
in ways which promote and maintain good health” [12,13]. 
Studies show that individuals with low HL more often engage 
in high-risk behaviours, make poor use of healthcare [14,15] 
and record poorer health outcomes [14-16]. In infectious 
diseases generally, evidence suggests that low HL levels may be 
associated with failure to engage in protective health behaviours 
(e.g. vaccinations, medication adherence and self-care) [17]. In 
the case of TB, research shows that hard-to-reach populations, 
including drug-using populations, have low awareness about 
TB clinical onset, how to access diagnostic and treatment 
services, to self-administer medication, and the dangers of 
developing resistance to TB medications [4].
Different approaches may be needed to raise TB HL within 
hard-to-reach populations [4]. For instance, nurse case 
management combined with TB education can improve 
treatment adherence and completion among homeless 
populations [18] and counseling combining health education 
with strategies to strengthen patients’ self-efficacy can increase 
adherence among people with poor HL [19]. Adjunctive 
Contingency Management (CM) to promote engagement with 
treatment and the attainment of health behaviours consistent 
with treatment goals is also recommended [20,21]. The 
combination of educational interventions and CM has achieved 
better treatment adherence and treatment completion - one 
of the biggest challenges when treating TB-among drug users 
[22]. This study tested trial procedures, estimated recruitment 
and attrition rates, and obtained preliminary measures on the 
effectiveness of an enhanced intervention to increase TB HL 
among drug users. It also assessed the feasibility of using CM to 
target TB-related behavioural actions among drug service users.
Materials and Methods
Design and interventions: We conducted a three-arm parallel 
pilot Randomized Controlled Trial (RCT) [23,24] with three 
study points (T0 = baseline, T1 = post-intervention and T2 = 
2-months follow-up) (Figure 1). The standard intervention 
(Group 1= G1) was a bespoke TB information booklet with 
user-friendly language and content specific to drug users/prison 
populations. The enhanced intervention delivered to both 
Groups 2 (G2) and 3 (G3), was a 1-hour seminar comprising: 
(a) an interactive quiz about TB, (b) a visual presentation 
during which participants interventions/questions fostered a 
dynamic and interactive environment, and (d) participants’ 
written feedback. Contents were mapped in both booklet and 
seminars to secure comparability of interventions regarding 
their contents.
The enhanced intervention + CM (G3) consisted of the seminar 
plus a brief one-to-one meeting with a researcher at which 
participants were invited to target an agreed TB-related action 
which, if completed and evidenced within two months (T2), 
was reinforced by a £10 voucher (i.e., CM).
Settings, participants and randomization: Two Westminster 
Drug Project (WDP) sites in London hosted this study between 
April and July 2017. Eligible participants were active service 
users, over 18 years old and in heroin and/or crack treatment 
(sample frame = 348). We were able to contact 164 (47%) and 
allocated those who consented to participate to each of the 
trial groups using a random permuted size-3 block protocol.
Ethical procedures: The project was approved by WDP 
Medicines Management Committee and Ethics approval was 
granted by the Natural Sciences ethics committee (Middlesex 
University, Ref.: 2233). Eligible service users received written 
and oral study information. Those who agreed to participate 
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Figure 1: RCT to improve Health Literacy regarding TB among Drug Users. Study Design at a glance. London, 2017.
signed a consent form. Participants received £5 and £10 
supermarket vouchers at each study point for their participation.
Data collection instruments: Three questionnaires were 
piloted at each study point. The T0 questionnaire surveyed socio 
demographic characteristics, general health (SF12v2®) [25,26], 
drug use, prison history, alcohol (CAGE) [27], smoking 
(FTND) [28], and TB knowledge. The T1 and T2 questionnaires 
included the TB knowledge scale only. The TB scale (16 items) 
was constructed from the Knowledge, Attitudes and Practices 
(KAP) and the TB Knowledge Assessment Questionnaire 
(TKAQ) [29] plus ad hoc items and measured knowledge in a 
range from 0 (No knowledge) to 21 (High knowledge) (Box 1).
Data collection procedures: At T0 the baseline questionnaire 
was implemented. At T1: G1 participants were invited to read 
the TB booklet while G2 and G3 participants were invited to a 
TB seminar. In all cases the TB knowledge scale was re-applied 
afterwards. At T2 participants completed the TB knowledge 
scale once again. G3 participants were additionally asked for 
evidence of their completed target action.
Data analysis: Descriptive statistics was conducted to describe 
the sample’ sociodemographic characteristics, general health, 
drug, alcohol and tobacco use, prison history and TB knowledge 
scores. SF-12v2® standardized T scores were calculated for each 
health domain [26]. Cronbach’s alpha was used to evaluate the 
internal reliability of the TB knowledge scale. Paired Samples 
t test at 99% CI was run to measure knowledge change. 
ANCOVA was used to test between-groups knowledge change. 
Data analysis was undertaken using SPSS v. 21.
Results
A 3-weeks recruitment period was used to repeatedly contact 
all eligible participants in the sample frame with valid contact 
details (164 out of the 348 records). Eighty-three (50.6%) 
declined to participate (overwhelming majority for personal 
reasons), while 81 (49.4%) agreed to a scheduled appointment 
where consent and baseline measures could be obtained. 
Forty-two attended and all consented to study participation 
(response rate = 25.6%). The overall attrition rate was 43%, 
but attrition was higher in G2 and G3 than G1 (Figure 2).
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Is TB caused by?
Bacteria  Virus  Parasite I don’t know
How can a person get TB?
Through handshakes
Through the air when a person with TB coughs or sneezes
Through sharing dishes/eating from the same plate
Through touching items in public places (door knobs, handles in transportation, etc.)
Sexual transmission from infected person
Kissing an infected person
Through infected blood transfusion
Other (please explain)  Do not know
Which of the following is the best screening test TB?
Blood test Urine test  Chest X ray  Saliva and sputum examination
Skin test  Do not know
Can TB be cured?
Yes    No   Do not know
Box 1: Sample of questions used to assess health literacy regarding Tuberculosis.
Figure 2: RCT to improve Health Literacy regarding TB among Drug Users. Recruitment flowchart. London, 2017.
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G1 G2 G3 Total
n (15) % (35.7) n (13) % (31.0) n (14) % (33.3) n (42) % (100)
Gender
Man 11 26.2 11 26.2 11 26.2 33 78.6
Woman 4 9.5 2 4.8 3 7.1 9 21.4
Age
23-38 2 4.8 4 9.5 5 11.9 11 26.2
39-49 4 9.5 4 9.5 5 11.9 13 31.0
>50 9 21.4 5 11.9 4 4.8 18 42.9
Education
<Graduate 13 31.0 13 31.0 11 26.2 37 88.1
>Graduate 2 4.8 0 0.0 3 7.1 5 11.9
Ethnicity
White 10 24.4 7 17.1 8 19.5 25 61.0
South Asian 1 2.4 1 2.4 1 2.4 3 7.3
Caribbean 1 2.4 2 4.9 0 0.0 3 7.3
Mixed 2 4.9 3 7.3 3 7.3 8 19.5
Other 0 0.0 0 0.0 2 4.9 2 4.9
Religion
Christianity 11 26.8 5 12.2 5 12.2 21 51.2
Islam 1 2.4 1 2.4 2 4.9 4 9.8
Other 2 4.9 3 7.3 1 2.4 6 14.6
None 1 2.4 4 9.8 5 12.2 10 24.4
Sexuality
Heterosexual 14 34.1 12 29.3 12 29.3 38 92.7
Bisexual 1 2.4 0 0.0 1 2.4 2 4.9
Other 0 0.0 1 2.4 0 0.0 1 2.4
Living…. 
Alone 8 19.0 9 21.4 8 19.0 25 59.5
Spouse/partner/family 5 11.9 4 9.5 3 7.1 12 28.6
Other 2 4.8 0 0.0 3 7.1 5 11.9
Living arrangements
Privately rented/owned 5 11.9 6 14.3 7 16.7 18 42.9
Social housing 6 14.3 6 14.3 5 11.9 17 40.5
Homeless 2 4.8 0 0.0 1 2.4 3 7.1
Other 2 4.8 1 2.4 1 2.4 4 9.5
Work status 
Employed 3 7.1 1 2.4 1 2.4 5 11.9
Unemployed/benefits 11 26.2 11 26.2 10 23.8 32 76.2
Other 1 2.4 1 2.4 1 2.4 5 11.9
Ever been in prison
Yes 9 21.4 8 19.0 7 16.7 24 57.1
No 6 14.3 5 11.9 7 16.7 18 42.9
Table 1: Sample socio-demographic characteristics by trial group. London, 2017.
G1 = Group 1 (Standard intervention / control group) G2 = Group 2. Intervention group (Enhanced intervention) 
G3 = Intervention group (Enhanced intervention + contingency management)
Participants were mostly men (79%) with a mean age of 
45.9 years old (SD = 10; range = 23-65). Sixty-one per cent 
were white and 20% had mixed ethnicity. Most (60%) lived 
alone, 29% in a family unit, 43% in their own property/
privately rented and 41% in social housing. Most (76%) were 
unemployed/receiving sickness benefits while 12% worked. 
More than half (57%) had been in prison (Table 1).
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G1 G2 G3 Total
n % n % n % n %
Drug treatment demand (n=39)
Heroin 4 10.3 6 15.4 3 7.7 13 33.3
Crack cocaine 3 7.7 0 0.0 3 7.7 6 15.4
Both 6 15.4 6 15.4 8 15.4 20 51.3
Heroin use (n=42)
Never 1 2.4 0 0.0 2 4.8 3 7.1
Ever 5 11.9 1 2.4 3 7.1 9 21.4
Last year 1 2.4 2 4.8 1 2.4 4 9.5
Last 3 months 8 19.0 10 23.8 8 19.0 26 61.9
Street methadone (n=42)
Never 9 21.4 9 21.4 8 19.0 26 61.9
Ever 4 9.5 2 4.8 2 4.8 7 16.7
Last year 1 2.4 1 2.4 2 4.8 4 9.5
Last 3 months 1 2.4 1 2.4 3 7.1 5 11.9
Injected drugs (n=42)
Never 8 19.0 3 7.1 8 19.0 19 45.2
Ever 5 11.9 7 16.7 2 4.8 14 33.3
Last year 1 2.4 1 2.4 2 4.8 4 9.5
Last 3 months 1 2.4 2 4.8 2 4.8 5 11.9
Shared injecting equipment (n=23)
Never 2 8.7 6 26.1 5 21.7 13 56.5
Ever 3 13.0 4 17.4 2 8.7 9 39.1
Last year 1 4.3 0 0.0 0 0.0 1 4.3
Inhaled heroin (n=42)
Never 4 9.5 0 0.0 5 11.9 9 21.4
Ever 5 11.9 1 2.4 4 9.5 10 23.8
Last year 1 2.4 4 9.5 2 2.4 7 16.7
Last 3 months 5 11.9 8 19.0 3 7.1 16 38.1
Shared inhaling equipment (n=29)
Never 5 17.2 4 13.8 4 13.8 13 44.8
Rarely/sometimes 3 10.3 6 20.7 3 10.3 12 41.4
Most/all the time 2 10.3 1 3.4 1 3.4 4 13.8
Cannabis/marihuana use (n=42)
Never 2 4.8 1 2.4 3 7.1 6 14.3
Ever 7 16.7 4 9.5 7 16.7 18 42.9
Last year 0 0.0 1 2.4 0 0.0 1 2.4
Fifty-one per cent of the sample was in drug treatment for 
use of both crack-cocaine and heroin, 33% used heroin only 
and the rest (15%) crack/cocaine only. The majority (62%) 
had used heroin in the last three months, 41% cannabis and 
62% crack-cocaine. Although 39% of the sample had shared 
injecting equipment, only 4% had done so in the last year. The 
vast majority (93%) smoked and 54% had moderate nicotine 
dependence. Half drank alcohol and amongst these, 52% 
drank at potentially harmful levels as per CAGE scores. Drug 
use behaviours with high TB transmission risk were explored 
by questions focusing on sharing and drug use proximal to 
users: of the 33 participants (79%) who had inhaled heroin 
41% shared equipment sometimes/rarely while 14% shared 
most/all of the time. Spliff sharing happened sometimes and 
most/all the time among 58% and 26% respectively of the 
19 participants who smoke cannabis/marihuana (Table 2).
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G1 G2 G3 Total
n % n % n % n %
Last 3 months 6 14.3 7 16.7 4 9.5 17 40.5
Shared splifs (last year/3 months) (n=19)
Never 3 15.8 0 0.0 0 0.0 3 15.8
Sometimes 2 10.5 7 36.8 2 10.5 11 57.9
All the time 1 5.3 2 10.5 2 10.5 5 26.3
Alcohol use (n=42)
Yes 7 16.7 6 14.3 8 19.0 21 50.0
No 8 19.0 7 16.7 6 14.3 21 50.0
Potential alcohol problem (n=21)
Yes 2 9.5 4 19.0 5 23.8 11 47.6
No 5 23.8 2 9.5 3 14.3 10 52.4
Smoking dependence (n=39)
Low 0 0.0 1 2.6 0 0.0 1 2.6
Low to moderate 0 0.0 4 10.3 9 23.1 13 33.3
Moderate 10 10.3 7 17.9 4 10.3 21 53.8
High 3 7.7 1 2.6 0 0.0 4 10.3
Table 2: Drug, alcohol use and risk behaviours regarding TB by trial group. London 2017.
G1 = Group 1 (Standard intervention / control group) G2 = Group 2. Intervention group (Enhanced intervention) 
G3 = Intervention group (Enhanced intervention + contingency management)
Most SF-12v2® health dimensions scores were considerably 
below general population norm, with the exception of Physical 
Functioning (mean = 45.2, SD = 12.1, range = 22.1-56.5) and 
Vitality (mean = 50.9, SD = 11.0, range = 27.6-67.9) where 
mean scores were close to general population norms (Figure 3).
Figure 3: RCT to improve Health Literacy regarding TB among Drug Users. Health status. SF12 normative scores. London, 2017.
1Mental Component Summary score; 2Physical Component Summary score.
Dotted line: Reference mean score of the normative population (U.S. 1998 general population).
Black points: Mean score of each health domain.
T0 T1 T2
Mean/SD Range Mean/SD Range T1-T0 MD Mean Range T2 - T0 MD T2 - T1 MD
G1 11.7/3.5 5-16 16.9/3.6 10-21 5.2 15.4/2.5 11-18 3.7 -1.5
G2 11.7/3.1 4-17 16.7/3.4 11-21 5.0 15.3/1.6 13-17 3.6 -1.4
G3 11.1/5.2 0-18 18.9/1.8 16-21 7.8 16.5/3.1 10-19 5.4 -2.4
All 11.5/3.9 0-18 17.4/3.2 10-21 5.9 15.8/2.5 10-19 4.3 -1.6
Table 3: Knowledge scores and mean differences across study points by trial group and whole sample. London, 2017.
G1 = Group 1 (Standard intervention / control group) G2 = Group 2. Intervention group (Enhanced intervention) 
G3 = Intervention group (Enhanced intervention + contingency management)
One participant had been diagnosed as TB positive (and 
successfully completed treatment.) HCV prevalence was 33.3% 
but they all were HIV negative. Analysis of cumulative exposure 
to risk factors for TB (Drug abuse, Homelessness, HIV and/
or HCV and exposure to high population density such as 
imprisonment) shows that while 100% exhibited at least one 
risk factor (drug abuse),38% reported exposure to two risk 
factors,29% to three, and 2% had exposure to four TB risk 
factors.
The internal reliability of the TB knowledge scale was good 
(Cronbach’s α = 0.706). TB knowledge average score increased 
5.9 for the whole sample from T0 to T1, from 11.5 at T0 
(SD = 3.9, range = 0-18) to 17.4 at T1 (SD = 3.2, range = 
10-21). Even though the average score at T2 declined to 15.8 
(SD = 2.5, range = 10-19) it still represented 4.3 points (20% 
increase) from T0 (Table 3).
The increase of knowledge for the 31 observations with data 
from T1 compared to T0 revealed a MD = 4.9 (SD = 2.9; 
99% CI = 3.4-6.4) and was statistically significant (t30 = 
-9.261; p = 0.000). This was also the case for the knowledge 
increase at T2 compared with T0 (n = 24; MD = 2.8; SD = 
2.4; 99% CI = 1.4-4.1; t23 = 5.667; p = 0.000). However, 
ANCOVA analysis did not reveal statistically significant pre-
post-intervention differences between groups (F = 0.104; p 
= 0.7). Loss of follow up in G3 (T0 = 14 participants, T2 = 
8) compromised our assessment of whether CM promoted 
TB health-related behavioural actions. Amongst the 8 G3 
participants who reached follow-up, 50% provided acceptable 
evidence of completion of the target action agreed at T1. 
Actions ranged from personal preventive measures (e.g. 
request TB screening from GP) to public health-oriented 
actions such as conversations with friends about TB.
Discussion
This small pilot RCT aimed to increase HL regarding TB 
among drug users in treatment and provides estimates of 
recruitment and attrition rates. In our study a 26% response 
rate was achieved and an overall 43% attrition rate was 
suffered across the study timetable. Attrition was substantially 
different in G1 compared to G2 and G3. This can be explained 
because the intervention in G1 took place immediately after 
baseline assessment. Both recruitment and retention rates are 
notoriously difficult to keep at acceptable levels in research 
including hard-to-reach populations [30] and the rigour in 
sampling strategies for experimental designs often prevents 
from implementing other sampling strategies and correction 
measures (e.g. snowballing) which introduce selection and 
gatekeeper biases [31]. However, lessons learnt from this pilot 
include the need to provide motivating incentives to both 
participants and participating sites, and facilitating seminar 
attendance by scheduling them in early evenings.
Despite its small size, this study provides evidence that TB HL 
among drug users in treatment can be improved. We achieved 
a statistically significant increment in knowledge across the 
cohort. Reasons for the lack of differential results between the 
intervention groups may be explained by the implementation 
conditions; while a booklet (control intervention) is not 
different from the standard exposure to information that drug 
service users might routinely experience, in our study control 
participants were given time to read the booklet in situ and 
knew they would be asked questions about TB afterwards. 
This is not the usual implementation of printed-material 
interventions where people are given the material to take home 
with no expectation of being quizzed about it. This might 
explain the very positive results obtained in the control group 
and the lack of statistically significant differences compared to 
those exposed to the experimental interventions.
A limitation of this study is the uncertainty about what level 
of HL our interventions made an impact upon. In his classic 
taxonomy of HL levels, Nutbeam proposed three levels: 
functional (basic skills in reading and writing necessary for 
effective functioning in a health context), interactive (more 
advanced cognitive literacy and social skills that enable 
active participation in health care) and critical (the ability 
 Submit Manuscript                                                                                  .08.                                                    Ocimum Scientific Publishers
https://doi.org/10.33513/DDAD/1901-02                                                                                                         Drug Dependence and Addiction - Open Access Journal
to both critically analyse and use information to participate 
in actions tackling structural barriers to health [32]. Our TB 
knowledge scale, directly targeted functional HL, which while 
a prerequisite to higher level HL, does not enable us to assess 
whether participants achieved improved interactive and critical 
HL. This is a shared problem across other fields of infectious 
diseases where a lack of studies tackling interactive and critical 
HL has been identified and exacerbated in relation to assessing 
the impact of TB HL [17].
The lack of validated scales posed an additional challenge. 
While KAP and TKAQ [29] provided a significant number 
of items, there were no items that would specifically survey 
knowledge about TB among drug users. Both KAP and TKAQ 
include elements of the scales to measure knowledge among 
syringe exchange programs users in New York City in the 
mid-90s [33], and more recently in Estonia in 2008/9 [11]. 
However, these seminal scales were too basic (dichotomous 
items only) and generic with no specific contents for drug 
using populations (e.g. the impact of rifampicin on methadone 
drug clearance and reduction of its half-life, that indicates a 
concomitant dose increase during treatment with rifampicin) 
[34]. However, while its psychometric characteristics and 
unknown, the 16-items knowledge scale developed for this 
study provides the first instrument specifically designed for 
drug treatment populations and merits development and 
testing in further studies.
This study also included an element of CM as recent UK 
research has also shown that simple positive reinforcement 
schedules can promote significantly increased adherence to 
physical health interventions such as Hepatitis B vaccination 
in drug treatment populations [35]. In our study, CM was 
applied to provide an incentive for subjects in G3 to engage in 
TB-related actions. The small study sample size precludes any 
sophisticated analysis regarding the success of the CM element. 
However, the completion rate of 50% suggests that inclusion 
of this element is feasible, should be formally assessed in a 
further RCT and may merit evaluation of its implementation 
in routine clinical practice.
Conclusion
This study achieved three significant objectives: Firstly, it 
demonstrates that it is feasible to deliver therapeutic tools 
to increase TB HL to people in drug treatment. The two 
interventions designed are flexible enough to be integrated 
in drug services health educational activities relating to HIV 
and HCV, which are already routinely provided. Secondly, 
it provides evidence that such interventions can be effective 
in increasing TB HL among this population and may make 
a difference in how well equipped this population is to 
protect themselves against this infection. Thirdly, the study 
demonstrates that it would be feasible to implement full RCT 
and provides data upon to power that. On the basis of our 
findings we argue that such a trial is needed to test and identify 
the therapeutic options that most efficiently and effectively 
promote the best outcomes.
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